SCHOFIELD, Wis., Oct. 26, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that it is building upon its recently launched print advertising campaign for its migraine medication LipiGesic™ M.
SCHOFIELD, Wis., Oct. 26, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that it is building upon its recently launched print advertising campaign for its migraine medication LipiGesic™ M.